| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
3,115 |
2,664 |
$5.40M |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
2,023 |
1,748 |
$3.63M |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
1,299 |
961 |
$3.03M |
| S0013 |
Esketamine, nasal spray, 1 mg |
510 |
291 |
$1.01M |
| J0578 |
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy |
369 |
342 |
$631K |
| J0577 |
Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy |
19 |
12 |
$9K |
| J0576 |
Injection, buprenorphine extended-release (brixadi), 1 mg |
33 |
26 |
$4K |
| C9154 |
Injection, buprenorphine extended-release (brixadi), 1 mg |
23 |
13 |
$0.00 |